HER2/neu抗體 |
|
產(chǎn)品名稱 : HER2/neu抗體
產(chǎn)品類別 : IVD診斷抗體原料
品 牌 : GenomeMe
貨 號(hào) : IHC042
規(guī) 格 : 0.1ml/1ml
|
|
詳細(xì)信息 |
|
純化方式 :
緩 沖 液 :
應(yīng)用說(shuō)明 :
形 態(tài) :
產(chǎn)品說(shuō)明 :
背景描述Description:
Her2/Neu(c-erbB-2)原癌基因是一種跨膜受體酪氨酸激酶,臨床上廣泛存在于多種腫瘤中。c-erbB-2蛋白的過(guò)度表達(dá)與乳腺導(dǎo)管癌、肺腺癌和胃腺癌有關(guān)。Her2和p53之間的相關(guān)性也已被證實(shí),因?yàn)檫@兩種蛋白的過(guò)度表達(dá)與膀胱癌的早期侵襲和轉(zhuǎn)移有關(guān)。
The Her2/Neu (c-erbB-2) proto-oncogene is a transmembrane receptor tyrosine kinase that is clinically indicated in a number of carcinomas. Overexpression of the c-erbB-2 protein has been associated with ductal breast cancer, as well as pulmonary and gastric adenocarcinomas. A correlation between Her2 and p53 has also been documented, as overexpression of both proteins has been associated with early invasion and metastasis in bladder cancer.
Specifications:
Clone IHC042
Source Mouse Monoclonal
Positive Control Breast Carcinoma
Dilution Range 1:50-1:200
參考文獻(xiàn)References:
Suthipintawong C, et al. Diagn Cytopathol. 1997; 17:127-33.
Alexiev BA, et al. Gen Diagn Pathol. 1997; 142:271-9.
Fernández Aceñero MJ, et al. Gen Diagn Pathol. 1997; 142:289-96.
Koeppen HKW, et al. Histopathology. 2001; 38:96-104.
Moch H, et al. Virchows Arch A Pathol Anat Histopathol. 1993; 423:329-34.
Cetin B, et al. Transl Gastroenterol Hepatol. 2016; 1:59.
|
|
{返回} |